Add BrightSurf on Google Email

New Alzheimer's risk gene discovered

A new study has identified a genetic variation in the Mucin 6 gene that may contribute to late-onset Alzheimer disease. The findings suggest a strong association between the genetic variant and the disease, implying a large effect size and opening up possibilities for future therapeutic targets.

SourceOxford University Press USA·JournalJournal of Neuropathology & Experimental Neurology·DateNov 21, 2019

Perturbed genes regulating white blood cells linked to autism genetics and severity

Researchers identified a critical gene network disrupted in autism spectrum disorder (ASD) that correlates with symptom severity. The findings suggest genetic factors influencing brain development during pregnancy are primary causes of ASD, providing potential biomarkers for early diagnosis and prediction of symptom severity.

SourceUniversity of California - San Diego·JournalNature Neuroscience·DateSep 23, 2019

Hemophilia three times more prevalent than thought

A new study by McMaster University researchers reveals that over 1,125,000 men globally have hemophilia, with 418,000 having severe forms of the disease. The study found a significant life expectancy disadvantage for those with hemophilia, particularly in lower-income countries.

SourceMcMaster University·JournalAnnals of Internal Medicine·DateSep 9, 2019

Finding a cause of neurodevelopmental disorders

Researchers identified the molecular mechanism linking a protein mutation with abnormal nervous system development in neurodevelopmental disorders. A complex of proteins called the SWI/SNF complex was found to be affected, leading to changes in gene expression and brain development.

SourceSalk Institute·JournalMolecular Cell·DateJul 30, 2019

Genes underscore five psychiatric disorders

A collaborative research project analyzing over 400,000 individuals identified several sets of genes marked across all five psychiatric disorders. These genes play a role in the same biological pathway or are active in the same tissue type, increasing risk for multiple disorders.

SourceUniversity of Queensland·JournalPsychological Medicine·DateJul 24, 2019

Saving Beethoven

Researchers at Harvard Medical School developed a precise gene-editing tool to target the faulty Tmc1 gene in Beethoven mice, achieving an unprecedented level of accuracy. The treatment successfully preserved hearing in mice with hereditary deafness, paving the way for potential treatments of other dominantly inherited genetic diseases.

SourceHarvard Medical School·JournalNature Medicine·DateJul 3, 2019

Researchers use machine-learning system to diagnose genetic diseases

A machine-learning system using clinical natural language processing and genome sequencing diagnose rare genetic diseases in record time, providing critical information to intensive care physicians. The automated pipeline achieved significant time-savings and concurred with expert manual interpretation in 97% of cases.

SourceRady Children's Institute for Genomic Medicine·JournalScience Translational Medicine·DateApr 24, 2019

Dr. Roger E. Stevenson receives Rimoin Lifetime Achievement Award from ACMG Foundation

Dr. Roger E. Stevenson, a senior clinical and research geneticist at the Greenwood Genetic Center, has received the 2019 ACMG Foundation David L. Rimoin Lifetime Achievement Award. The award recognizes his vision in founding the center, groundbreaking research on X-linked intellectual disability, and leadership in establishing programs...

Study estimates how common carriers of polyglutamine disease-associated gene variants are in general population

Researchers estimated how common carriers of intermediate and pathological range polyglutamine disease-associated gene variants were among the general population using data from five European studies. The study found that approximately 2% of participants carried intermediate range variants and 1% carried pathological range variants.

SourceJAMA Network·JournalJAMA Neurology·DateApr 1, 2019